Digitisation | January 14, 2022
Hekka Labs introduces decentralized chronic disease data management in South Asia
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
The authorization provides an additional treatment option against the Covid-19 virus in the form of a pill that can be taken orally
Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
2022 is going to be the year of opportunities and innovations from the medical industry in India
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
A first for the Asian market, addressing the health spends needs of over 200 million households.
Subscribe To Our Newsletter & Stay Updated
